[
    [
        {
            "time": "2021-06-23",
            "original_text": "复星医药：本公司孙公司药物上市注册申请获国家药监局批准",
            "features": {
                "keywords": [
                    "复星医药",
                    "药物",
                    "上市注册",
                    "国家药监局",
                    "批准"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药：本公司孙公司药物上市注册申请获国家药监局批准",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "国内首款CAR-T细胞疗法获批复星医药AH股齐涨",
            "features": {
                "keywords": [
                    "CAR-T",
                    "细胞疗法",
                    "获批",
                    "复星医药",
                    "AH股",
                    "齐涨"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国内首款CAR-T细胞疗法获批复星医药AH股齐涨",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "中国首款CAR-T产品获批上市，国产化大潮要来了吗？",
            "features": {
                "keywords": [
                    "CAR-T",
                    "产品",
                    "获批",
                    "上市",
                    "国产化",
                    "大潮"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中国首款CAR-T产品获批上市，国产化大潮要来了吗？",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "复星医药AH股齐拉升复星凯特CAR-T细胞治疗产品获批",
            "features": {
                "keywords": [
                    "复星医药",
                    "AH股",
                    "拉升",
                    "复星凯特",
                    "CAR-T",
                    "细胞治疗",
                    "获批"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药AH股齐拉升复星凯特CAR-T细胞治疗产品获批",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "国金证券：复星医药（600196.SH）中国首个CAR-T获批，维持“买入”评级",
            "features": {
                "keywords": [
                    "国金证券",
                    "复星医药",
                    "CAR-T",
                    "获批",
                    "买入",
                    "评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国金证券：复星医药（600196.SH）中国首个CAR-T获批，维持“买入”评级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]